Coupling of caspase-9 to Apaf1 in response to loss of pRb or cytotoxic drugs is cell-type-specific

EMBO Journal

Volumn 23, Issue 2, 2004, Pages 460-472

  Ho, Andrew T ^a   Li, Qin H ^a   Hakem, Razqallah ^b   Mak, Tak W ^b   Zacksenhaus, Eldad ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Apaf 1 Ced 4; Apoptosis; Caspase 9; E2F1; Myogenesis; Neurogenesis; Retinoblastoma

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 9; CYTOTOXIC AGENT; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; EMBRYO; GENE INACTIVATION; MOUSE; MUSCLE DEVELOPMENT; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CASPASE 9; CASPASES; CELLS, CULTURED; ENDOPLASMIC RETICULUM; FIBROBLASTS; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MUSCLE, SKELETAL; MUTATION; MYOBLASTS; NERVOUS SYSTEM; PROTEINS; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; STAUROSPORINE;

ANIMALIA;

EID: 1542380553     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.emboj.7600039     Document Type: Article

References (54)

1. Aravind L, Dixit VM, Koonin EV (2001) Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. Science 291: 1279-1284
2. Bitzer M, Armeanu S, Prinz F, Ungerechts G, Wybranietz W, Spiegel M, Bernlohr C, Cecconi F, Gregor M, Neubert WJ, Schulze-Osthoff K, Lauer UM (2002) Caspase-8 and Apaf-1-independent caspase-9 activation in Sendai virus-infected cells. J Biol Chem 277: 29817-29824
3. Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P (1998) Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 94: 727-737
4. Chau BN, Borges HL, Chen TT, Masselli A, Hunton IC, Wang JY (2002) Signal-dependent protection from apoptosis in mice expressing caspase-resistant Rb. Nat Cell Biol 4: 757-765
5. Chau BN, Wang JY (2003) Coordinated regulation of life and death by RB. Nat Rev Cancer 3: 130-138
6. Classon M, Harlow E (2002) The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2: 910-917
7. Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu SW, Dawson TM, Dawson VL, Park DS, Kroemer G, Slack RS (2002) Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 158: 507-517
8. Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, Rosova I, Kulans LA, Fu X, Weinberg JS, Heinecke JW, Roth KA, Weintraub SJ (2002) Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell 111: 51-62
9. Ferri KF, Kroemer G (2001) Organelle-specific initiation of cell death pathways. Nat Cell Biol 3: E255-263
10. Forcet C, Ye X, Granger L, Corset V, Shin H, Bredesen DE, Mehlen P (2001) The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation. Proc Natl Acad Sci USA 98: 3416-3421
11. Fujita E, Egashira J, Urase K, Kuida K, Momoi T (2001) Caspase-9 processing by caspase-3 via a feedback amplification loop in vivo. Cell Death Differ 8: 335-344
12. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501
13. Gill RM, Hamel PA (2000) Subcellular compartmentalization of E2F family members is required for maintenance of the postmitotic state in terminally differentiated muscle. J Cell Biol 148: 1187-1201
14. Guo Z, Shi Y, Hiroki Y, Mak T, Zacksenhaus E (2001) Inactivation of the retinoblastoma tumor suppressor induces Apaf-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res 61: 8395-8400
15. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM, Mak TW (1998) Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94: 339-352
16. Hara H, Takeda A, Takeuchi M, Wakeham AC, Itie A, Sasaki M, Mak TW, Yoshimura A, Nomoto K, Yoshida H (2002) The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes. J Immunol 168: 2288-2295
17. Haraguchi M, Torii S, Matsuzawa S, Xie Z, Kitada S, Krajewski S, Yoshida H, Mak TW, Reed JC (2000) Apoptotic protease activating factor 1 (Apaf-1)-independent cell death suppression by Bcl-2. J Exp Med 191: 1709-1720
18. Inohara N, Nunez G (2003) NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 3: 371-382
19. Jiang Z, Gou Z, Saad F, Ellis J, Zacksenhaus E (2001) Retinoblastoma gene promoter directs transgene expression exclusively to the nervous system. J Biol Chem 276: 593-600
20. Jiang Z, Liang P, Leng R, Guo Z, Liu Y, Liu X, Bubnic S, Keating A, Murray D, Goss PE, Zacksenhaus E (2000) E2F1 and p53 are dispensable whereas p21Waf1/Cip1 cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis. Dev Biol 227: 28-41
21. Jiang Z, Zacksenhaus E (2002) Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma. J Cell Biol 156: 185-198
22. Jiang Z, Zacksenhaus E, Gallie BL, Phillips RA (1997) The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene 14: 1789-1797
23. Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H, Su MS, Rakic P, Flavell RA (1998) Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94: 325-337
24. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489
25. Lin WC, Lin FT, Nevins JR (2001) Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 15: 1833-1844
26. Lipinski MM, Jacks T (1999) The retinoblastoma gene family in differentiation and development. Oncogene 18: 7873-7882
27. Liu Y, Zacksenhaus E (2000) E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses. Oncogene 19: 6065-6073
28. Lytton J, Westlin M, Hanley MR (1991) Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem 266: 17067-17071
29. Macleod KF, Hu Y, Jacks T (1996) Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J 15: 6178-6188
30. MacPherson D, Sage J, Crowley D, Trumpp A, Bronson RT, Jacks T (2003) Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system. Mol Cell Biol 23: 1044-1053
31. McNeish IA, Bell S, McKay T, Tenev T, Marani M, Lemoine NR (2003) Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway. Exp Cell Res 286: 186-198
32. Morgenbesser SD, Williams BO, Jacks T, DePinho RA (1994) p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371: 72-74
33. Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F, Muller H, Helin K (2001) Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 3: 552-558
34. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S, Loh DY (1995) Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267: 1506-1510
35. Nahle Z, Polakoff J, Davuluri RV, McCurrach ME, Jacobson MD, Narita M, Zhang MQ, Lazebnik Y, Bar-Sagi D, Lowe SW (2002) Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 4: 859-864
36. Okada H, Suh WK, Jin J, Woo M, Du C, Elia A, Duncan GS, Wakeham A, Itie A, Lowe SW, Wang X, Mak TW (2002) Generation and characterization of Smac/DIABLO-deficient mice. Mol Cell Biol 22: 3509-3517
37. Ostrovsky O, Bengal E (2003) The mitogen-activated protein Kinase cascade promotes myoblast cell survival by stabilizing the cyclin-dependent Kinase inhibitor, p21WAF1 protein. J Biol Chem 278: 21221-21231
38. Phillips AC, Ernst MK, Bates S, Rice NR, Vousden KH (1999) E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell 4: 771-781
39. Rao RV, Castro-Obregon S, Frankowski H, Schuler M, Stoka V, del Rio G, Bredesen DE, Ellerby HM (2002) Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J Biol Chem 277: 21836-21842
40. Ricci JE, Waterhouse N, Green DR (2003) Mitochondrial functions during cell death, a complex (I-V) dilemma. Cell Death Differ 10: 488-492
41. Sherr CJ (2000) The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 60: 3689-3695
42. Simpson MT, MacLaurin JG, Xu D, Ferguson KL, Vanderluit JL, Davoli MA, Roy S, Nicholson DW, Robertson GS, Park DS, Slack RS (2001) Caspase 3 deficiency rescues peripheral nervous system defect in retinoblastoma nullizygous mice. J Neurosci 21: 7089-7098
43. Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW, Lowe SW (1999) Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284: 156-159
44. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C, Lowe SW (2001) Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409: 207-211
45. Tsai KY, Hu Y, Macleod KF, Crowley D, Yamasaki L, Jacks T (1998) Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell 2: 293-304
46. Vooijs M, Berns A (1999) Developmental defects and tumor predisposition in Rb mutant mice. Oncogene 18: 5293-5303
47. Wang J, Helin K, Jin P, Nadal-Ginard B (1995) Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1. Cell Growth Differ 6: 1299-1306
48. Wu L, de Bruin A, Saavedra HI, Starovic M, Trimboli A, Yang Y, Opavska J, Wilson P, Thompson JC, Ostrowski MC, Rosol TJ, Woollett LA, Weinstein M, Cross JC, Robinson ML, Leone G (2003) Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 421: 942-947
49. Yoshida H (2003) The role of apaf-1 in programmed cell death: from worm to tumor. Cell Struct Funct 28: 3-9
50. Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM, Mak TW (1998) Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94: 739-750
51. Yoshida H, Okada Y, Kinoshita N, Hara H, Sasaki M, Sawa H, Nagashima K, Mak TW, Ikeda K, Motoyama N (2002) Differential requirement for Apaf1 and Bcl-X(L) in the regulation of programmed cell death during development. Cell Death Differ 9: 1273-1276
52. Zacksenhaus E (2003) Alternative reading frame suggests an alternative model for Retinoblastoma. Cell Cycle 2: 27-30
53. Zacksenhaus E, Jiang Z, Chung D, Marth J, Phillips RA, Gallie BL (1996) pRb controls cell proliferation, differentiation and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev 10: 3051-3064
54. Zaidi AU, D'Sa-Eipper C, Brenner J, Kuida K, Zheng TS, Flavell RA, Rakic P, Roth KA (2001) Bcl-X(L)-caspase-9 interactions in the developing nervous system: evidence for multiple death pathways. J Neurosci 21: 169-175